A microRNA signature of response to erlotinib is descriptive of TGFβ behaviour in NSCLC

A microRNA signature of response to erlotinib is descriptive of TGFβ behaviour in NSCLC

Abstract Our previous work identified a 13-gene miRNA signature predictive of response to the epidermal growth factor receptor (EGFR) inhibitor, erlotinib, in Non-Small Cell Lung Cancer cell lines. Bioinformatic analysis of the signature showed a functional convergence on TGFβ canonical signalling....

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Madeline Krentz Gober, James P. Collard, Katherine Thompson, Esther P. Black
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/63a108947c5040c98b9e1ac1ac2632b6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares